Disability and mental health service users got a ‘sense of relief’ after receiving their first Covid-19 vaccines this week.
The roll-out continued with vulnerable service users and those aged 69 to 65 at the LYIT vaccination centre in recent days.
L to R, Francis Chan, Bernie O’Neill, Margo Haughey, Dayna Burn, Nuala McGonigle and Jonathan Scanlon.
Bridie McFadden with Peter McFadden as Nuala McGonigle administers Peter’s vaccine.
Ann Marie Crosse (CHO 1 Covid Vaccination Project Lead) speaking amid much activity, said “We are delighted for the community. For the service users of disability and mental health here in Donegal to be getting the vaccine.”
Ann Marie said: “There is a great emphasis on looking after the clients from they arrive to when they leave the centre”.
Peter McFadden was asked how he felt after receiving his vaccination and said “I feel 100%, its a great day for the parish.”
Mr. John McCardle, Area Director of Nursing Donegal Mental Health Services stated: “we in the mental health services are delighted that we have been able to facilitate the vaccine to vulnerable service users in our community.”
Vaccinations commenced this week at Letterkenny IT vaccination centre for those aged 69 to 65 who had registered via the online portal on www.hse.ie
L to R Pauline McGarvey, Anne Robinson, Ivan Stevenson, Jessica McClure and Margo Haughey
People are able to register using their PPS number, Eircode, a mobile phone number and an email address. Alternatively, people can call HSELive on 1850 24 1850 or 01 240 8787 to register over the phone from 8am to 8pm, 7 days a week.
A spokesperson for the HSE said: “We wish to encourage any remaining 65-69 year olds to register- this includes ALL in this age group including those in Group 4 with health conditions and at very high risk of Covid disease.
“The programme is agile and responsive to any EU or global changes and this supports rapid reaction to developments in relation to the vaccine, such as the changes last week with new advice on AstraZeneca, the pausing of the roll out of the Janssen vaccine in Europe.”
